| Authors: |
Carrier A; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94800 Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94800 Villejuif, France., Manghi P; Department CIBIO, University of Trento, Trento, Italy.; Computational Biology Unit, Research and Innovation Centre, Fondazione Edmund Mach, via Mach 1, 38098 San Michele all'Adige, Italy., Silva CAC; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94800 Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94800 Villejuif, France., Lahmar I; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94800 Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94800 Villejuif, France., Suissa D; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94800 Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94800 Villejuif, France., Iebba V; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94800 Villejuif Cedex, France., Almonte AA; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94800 Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94800 Villejuif, France., Ajami NJ; Platform for Innovative Microbiome and Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Birebent R; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94800 Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94800 Villejuif, France., Laheurte C; Université de Franche-Comté, EFS, INSERM, UMR 1098 RIGHT, F-25000 Besançon, France., Schreibelt G; Medical BioSciences, Radboud university medical center, Nijmegen, the Netherlands., Lemant L; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94800 Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94800 Villejuif, France., Fahrner JE; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94800 Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94800 Villejuif, France., de Sousa E; ImmunoTherapy/ImmunoSurgery, Champalimaud Centre for the Unknown, Lisboa, Portugal., Berthier F; Life Sciences, R&D BioMérieux, Marcy l'Etoile, France., Villemonteix J; Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint-Louis, AP-HP, Université de Paris, 75010 Paris, France.; INSERM UMR 976, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France., Chevalier MF; INSERM UMR 976, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France., Piccinno G; Department CIBIO, University of Trento, Trento, Italy., Hocquet D; Université de Franche-Comté, UMR 6249 Chrono-environnement, F-25000 Besançon, France; CHU de Besançon, Hygiène Hospitalière, F-25000 Besançon, France., Lebhar I; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94800 Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94800 Villejuif, France., Maeurer M; ImmunoTherapy/ImmunoSurgery, Champalimaud Centre for the Unknown, Lisboa, Portugal.; Medizinische Klinik, Johannes Gutenberg University Mainz, Germany., Caillat-Zucman S; Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint-Louis, AP-HP, Université de Paris, 75010 Paris, France.; INSERM UMR 976, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France., Kobold S; Division of Clinical Pharmacology, LMU University Hospital, Munich, LMU Munich, 80336 Munich, Germany.; German Cancer Consortium (DKTK), a partnership between LMU University Hospital and DKFZ, Heidelberg, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München-German Research Center for Environmental Health Neuherberg, 85764 Oberschleißheim, Germany., Kroemer G; Centre de Recherche des Cordeliers, INSERM U1138, Équipe Labellisée - Ligue Nationale contre le Cancer, Université Paris Cité, Sorbonne Université, Paris, France.; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.; Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France., Derosa L; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94800 Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94800 Villejuif, France., Launay O; Université Paris Cité; Inserm CIC 1417, I-Reivac; APHP, Hôpital Cochin, Paris, France., Pieper DH; Microbial Interactions and Processes Research Group, Helmholtz Centre for Infection Research, 38124 Braunschweig Germany., Vital M; Microbial Interactions and Processes Research Group, Helmholtz Centre for Infection Research, 38124 Braunschweig Germany.; Institute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany., Santos-Peral A; Division of Clinical Pharmacology, LMU University Hospital, Munich, LMU Munich, 80336 Munich, Germany., Zaucha M; Division of Clinical Pharmacology, LMU University Hospital, Munich, LMU Munich, 80336 Munich, Germany., García-Bengoa M; Division of Clinical Pharmacology, LMU University Hospital, Munich, LMU Munich, 80336 Munich, Germany., Thorn-Seshold J; Division of Clinical Pharmacology, LMU University Hospital, Munich, LMU Munich, 80336 Munich, Germany.; Faculty of Chemistry and Pharmacy, LMU Munich, Munich, Germany., Stirling H; Division of Clinical Pharmacology, LMU University Hospital, Munich, LMU Munich, 80336 Munich, Germany., Golden E; Department of Radiation Oncology, Weill Cornell Medicine, New York., Bol KF; Medical BioSciences, Radboud university medical center, Nijmegen, the Netherlands.; Department of Medical Oncology, Radboud university medical center, Nijmegen, the Netherlands., White MG; Department of Colon & Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Platform for Innovative Microbiome and Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sahasrabhojane PV; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Platform for Innovative Microbiome and Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hoballah YM; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Platform for Innovative Microbiome and Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Losh JS; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Platform for Innovative Microbiome and Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DePinho CR; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Platform for Innovative Microbiome and Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dondossola E; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., de Vries IJM; Medical BioSciences, Radboud university medical center, Nijmegen, the Netherlands., Adotevi O; Université de Franche-Comté, EFS, INSERM, UMR 1098 RIGHT, F-25000 Besançon, France.; Department of Medical Oncology, CHU, Besançon, France., Wargo JA; Platform for Innovative Microbiome and Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rothenfußer S; Division of Clinical Pharmacology, LMU University Hospital, Munich, LMU Munich, 80336 Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München-German Research Center for Environmental Health Neuherberg, 85764 Oberschleißheim, Germany., Segata N; Department CIBIO, University of Trento, Trento, Italy.; Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy., Formenti S; Department of Radiation Oncology, Weill Cornell Medicine, New York.; Sandra and Edward Meyer Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Zitvogel L; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Gustave Roussy Cancer Campus (GRCC), Clinicobiome, 94800 Villejuif Cedex, France.; Institut National de la Santé Et de la Recherche Médicale (INSERM) U1015, Equipe Labellisée-Ligue Nationale contre le Cancer, 94800 Villejuif, France.; Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS), Villejuif, France. |
